You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Global and Japan Healthcare Nanotechnology Market Size, Status and Forecast 2021-2027

It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.

The industry is crowded with producers and fierce competition. The U.S. has the highest share of income by region, at more than 48 percent.The key manufacturers are Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson & Johnson, Smith & Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Shire, Ipsen, Endo International etc. Top 3 companies occupied about 2% market share.
Market Analysis and Insights: Global Healthcare Nanotechnology Market
The global Healthcare Nanotechnology market size is projected to reach US$ 356790 million by 2027, from US$ 185750 million in 2020, at a CAGR of 9.6% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Healthcare Nanotechnology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Healthcare Nanotechnology market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Healthcare Nanotechnology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Healthcare Nanotechnology market.
Healthcare Nanotechnology Breakdown Data by Type
Nano Medical Devices
Nano Diagnosis
Nanomedicine has the highest percentage of revenue by type, with more than 86% in 2019.
Healthcare Nanotechnology Breakdown Data by Application
CNS Product
According to the application, anticancer and CNS products accounted for 17.56% and 22.70% of the market in 2019 respectively.
Based on regional and country-level analysis, the Healthcare Nanotechnology market has been segmented as follows:
North America
United States
Rest of Europe
South Korea
Southeast Asia
Rest of Asia-Pacific
Latin America
Middle East & Africa
Saudi Arabia
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Healthcare Nanotechnology market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2016-2021.

The following players are covered in this report:
Teva Pharmaceuticals
Merck & Co
Gilead Sciences
3M Company
Johnson & Johnson
Smith & Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Endo International

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Healthcare Nanotechnology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Nanomedicine
1.2.3 Nano Medical Devices
1.2.4 Nano Diagnosis
1.2.5 Others
1.3 Market by Application
1.3.1 Global Healthcare Nanotechnology Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Anticancer
1.3.3 CNS Product
1.3.4 Anti-infective
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Healthcare Nanotechnology Market Perspective (2016-2027)
2.2 Healthcare Nanotechnology Growth Trends by Regions
2.2.1 Healthcare Nanotechnology Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Healthcare Nanotechnology Historic Market Share by Regions (2016-2021)
2.2.3 Healthcare Nanotechnology Forecasted Market Size by Regions (2022-2027)
2.3 Healthcare Nanotechnology Industry Dynamic
2.3.1 Healthcare Nanotechnology Market Trends
2.3.2 Healthcare Nanotechnology Market Drivers
2.3.3 Healthcare Nanotechnology Market Challenges
2.3.4 Healthcare Nanotechnology Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Healthcare Nanotechnology Players by Revenue
3.1.1 Global Top Healthcare Nanotechnology Players by Revenue (2016-2021)
3.1.2 Global Healthcare Nanotechnology Revenue Market Share by Players (2016-2021)
3.2 Global Healthcare Nanotechnology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Healthcare Nanotechnology Revenue
3.4 Global Healthcare Nanotechnology Market Concentration Ratio
3.4.1 Global Healthcare Nanotechnology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Healthcare Nanotechnology Revenue in 2020
3.5 Healthcare Nanotechnology Key Players Head office and Area Served
3.6 Key Players Healthcare Nanotechnology Product Solution and Service
3.7 Date of Enter into Healthcare Nanotechnology Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Healthcare Nanotechnology Breakdown Data by Type
4.1 Global Healthcare Nanotechnology Historic Market Size by Type (2016-2021)
4.2 Global Healthcare Nanotechnology Forecasted Market Size by Type (2022-2027)

5 Healthcare Nanotechnology Breakdown Data by Application
5.1 Global Healthcare Nanotechnology Historic Market Size by Application (2016-2021)
5.2 Global Healthcare Nanotechnology Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Healthcare Nanotechnology Market Size (2016-2027)
6.2 North America Healthcare Nanotechnology Market Size by Type
6.2.1 North America Healthcare Nanotechnology Market Size by Type (2016-2021)
6.2.2 North America Healthcare Nanotechnology Market Size by Type (2022-2027)
6.2.3 North America Healthcare Nanotechnology Market Size by Type (2016-2027)
6.3 North America Healthcare Nanotechnology Market Size by Application
6.3.1 North America Healthcare Nanotechnology Market Size by Application (2016-2021)
6.3.2 North America Healthcare Nanotechnology Market Size by Application (2022-2027)
6.3.3 North America Healthcare Nanotechnology Market Size by Application (2016-2027)
6.4 North America Healthcare Nanotechnology Market Size by Country
6.4.1 North America Healthcare Nanotechnology Market Size by Country (2016-2021)
6.4.2 North America Healthcare Nanotechnology Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Healthcare Nanotechnology Market Size (2016-2027)
7.2 Europe Healthcare Nanotechnology Market Size by Type
7.2.1 Europe Healthcare Nanotechnology Market Size by Type (2016-2021)
7.2.2 Europe Healthcare Nanotechnology Market Size by Type (2022-2027)
7.2.3 Europe Healthcare Nanotechnology Market Size by Type (2016-2027)
7.3 Europe Healthcare Nanotechnology Market Size by Application
7.3.1 Europe Healthcare Nanotechnology Market Size by Application (2016-2021)
7.3.2 Europe Healthcare Nanotechnology Market Size by Application (2022-2027)
7.3.3 Europe Healthcare Nanotechnology Market Size by Application (2016-2027)
7.4 Europe Healthcare Nanotechnology Market Size by Country
7.4.1 Europe Healthcare Nanotechnology Market Size by Country (2016-2021)
7.4.2 Europe Healthcare Nanotechnology Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Healthcare Nanotechnology Market Size (2016-2027)
8.2 Asia-Pacific Healthcare Nanotechnology Market Size by Type
8.2.1 Asia-Pacific Healthcare Nanotechnology Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Healthcare Nanotechnology Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Healthcare Nanotechnology Market Size by Type (2016-2027)
8.3 Asia-Pacific Healthcare Nanotechnology Market Size by Application
8.3.1 Asia-Pacific Healthcare Nanotechnology Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Healthcare Nanotechnology Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Healthcare Nanotechnology Market Size by Application (2016-2027)
8.4 Asia-Pacific Healthcare Nanotechnology Market Size by Region
8.4.1 Asia-Pacific Healthcare Nanotechnology Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Healthcare Nanotechnology Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Healthcare Nanotechnology Market Size (2016-2027)
9.2 Latin America Healthcare Nanotechnology Market Size by Type
9.2.1 Latin America Healthcare Nanotechnology Market Size by Type (2016-2021)
9.2.2 Latin America Healthcare Nanotechnology Market Size by Type (2022-2027)
9.2.3 Latin America Healthcare Nanotechnology Market Size by Type (2016-2027)
9.3 Latin America Healthcare Nanotechnology Market Size by Application
9.3.1 Latin America Healthcare Nanotechnology Market Size by Application (2016-2021)
9.3.2 Latin America Healthcare Nanotechnology Market Size by Application (2022-2027)
9.3.3 Latin America Healthcare Nanotechnology Market Size by Application (2016-2027)
9.4 Latin America Healthcare Nanotechnology Market Size by Country
9.4.1 Latin America Healthcare Nanotechnology Market Size by Country (2016-2021)
9.4.2 Latin America Healthcare Nanotechnology Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Healthcare Nanotechnology Market Size (2016-2027)
10.2 Middle East & Africa Healthcare Nanotechnology Market Size by Type
10.2.1 Middle East & Africa Healthcare Nanotechnology Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Healthcare Nanotechnology Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Healthcare Nanotechnology Market Size by Type (2016-2027)
10.3 Middle East & Africa Healthcare Nanotechnology Market Size by Application
10.3.1 Middle East & Africa Healthcare Nanotechnology Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Healthcare Nanotechnology Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Healthcare Nanotechnology Market Size by Application (2016-2027)
10.4 Middle East & Africa Healthcare Nanotechnology Market Size by Country
10.4.1 Middle East & Africa Healthcare Nanotechnology Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Healthcare Nanotechnology Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Healthcare Nanotechnology Introduction
11.1.4 Amgen Revenue in Healthcare Nanotechnology Business (2016-2021)
11.1.5 Amgen Recent Development
11.2 Teva Pharmaceuticals
11.2.1 Teva Pharmaceuticals Company Details
11.2.2 Teva Pharmaceuticals Business Overview
11.2.3 Teva Pharmaceuticals Healthcare Nanotechnology Introduction
11.2.4 Teva Pharmaceuticals Revenue in Healthcare Nanotechnology Business (2016-2021)
11.2.5 Teva Pharmaceuticals Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Healthcare Nanotechnology Introduction
11.3.4 Abbott Revenue in Healthcare Nanotechnology Business (2016-2021)
11.3.5 Abbott Recent Development
11.4 UCB
11.4.1 UCB Company Details
11.4.2 UCB Business Overview
11.4.3 UCB Healthcare Nanotechnology Introduction
11.4.4 UCB Revenue in Healthcare Nanotechnology Business (2016-2021)
11.4.5 UCB Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Healthcare Nanotechnology Introduction
11.5.4 Roche Revenue in Healthcare Nanotechnology Business (2016-2021)
11.5.5 Roche Recent Development
11.6 Celgene
11.6.1 Celgene Company Details
11.6.2 Celgene Business Overview
11.6.3 Celgene Healthcare Nanotechnology Introduction
11.6.4 Celgene Revenue in Healthcare Nanotechnology Business (2016-2021)
11.6.5 Celgene Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Healthcare Nanotechnology Introduction
11.7.4 Sanofi Revenue in Healthcare Nanotechnology Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 Merck & Co
11.8.1 Merck & Co Company Details
11.8.2 Merck & Co Business Overview
11.8.3 Merck & Co Healthcare Nanotechnology Introduction
11.8.4 Merck & Co Revenue in Healthcare Nanotechnology Business (2016-2021)
11.8.5 Merck & Co Recent Development
11.9 Biogen
11.9.1 Biogen Company Details
11.9.2 Biogen Business Overview
11.9.3 Biogen Healthcare Nanotechnology Introduction
11.9.4 Biogen Revenue in Healthcare Nanotechnology Business (2016-2021)
11.9.5 Biogen Recent Development
11.10 Stryker
11.10.1 Stryker Company Details
11.10.2 Stryker Business Overview
11.10.3 Stryker Healthcare Nanotechnology Introduction
11.10.4 Stryker Revenue in Healthcare Nanotechnology Business (2016-2021)
11.10.5 Stryker Recent Development
11.11 Gilead Sciences
11.11.1 Gilead Sciences Company Details
11.11.2 Gilead Sciences Business Overview
11.11.3 Gilead Sciences Healthcare Nanotechnology Introduction
11.11.4 Gilead Sciences Revenue in Healthcare Nanotechnology Business (2016-2021)
11.11.5 Gilead Sciences Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Healthcare Nanotechnology Introduction
11.12.4 Pfizer Revenue in Healthcare Nanotechnology Business (2016-2021)
11.12.5 Pfizer Recent Development
11.13 3M Company
11.13.1 3M Company Company Details
11.13.2 3M Company Business Overview
11.13.3 3M Company Healthcare Nanotechnology Introduction
11.13.4 3M Company Revenue in Healthcare Nanotechnology Business (2016-2021)
11.13.5 3M Company Recent Development
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Details
11.14.2 Johnson & Johnson Business Overview
11.14.3 Johnson & Johnson Healthcare Nanotechnology Introduction
11.14.4 Johnson & Johnson Revenue in Healthcare Nanotechnology Business (2016-2021)
11.14.5 Johnson & Johnson Recent Development
11.15 Smith & Nephew
11.15.1 Smith & Nephew Company Details
11.15.2 Smith & Nephew Business Overview
11.15.3 Smith & Nephew Healthcare Nanotechnology Introduction
11.15.4 Smith & Nephew Revenue in Healthcare Nanotechnology Business (2016-2021)
11.15.5 Smith & Nephew Recent Development
11.16 Leadiant Biosciences
11.16.1 Leadiant Biosciences Company Details
11.16.2 Leadiant Biosciences Business Overview
11.16.3 Leadiant Biosciences Healthcare Nanotechnology Introduction
11.16.4 Leadiant Biosciences Revenue in Healthcare Nanotechnology Business (2016-2021)
11.16.5 Leadiant Biosciences Recent Development
11.17 Kyowa Hakko Kirin
11.17.1 Kyowa Hakko Kirin Company Details
11.17.2 Kyowa Hakko Kirin Business Overview
11.17.3 Kyowa Hakko Kirin Healthcare Nanotechnology Introduction
11.17.4 Kyowa Hakko Kirin Revenue in Healthcare Nanotechnology Business (2016-2021)
11.17.5 Kyowa Hakko Kirin Recent Development
11.18 Shire
11.18.1 Shire Company Details
11.18.2 Shire Business Overview
11.18.3 Shire Healthcare Nanotechnology Introduction
11.18.4 Shire Revenue in Healthcare Nanotechnology Business (2016-2021)
11.18.5 Shire Recent Development
11.18 Ipsen
.1 Ipsen Company Details
.2 Ipsen Business Overview
.3 Ipsen Healthcare Nanotechnology Introduction
.4 Ipsen Revenue in Healthcare Nanotechnology Business (2016-2021)
.5 Ipsen Recent Development
11.20 Endo International
11.20.1 Endo International Company Details
11.20.2 Endo International Business Overview
11.20.3 Endo International Healthcare Nanotechnology Introduction
11.20.4 Endo International Revenue in Healthcare Nanotechnology Business (2016-2021)
11.20.5 Endo International Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
  • PUBLISHED DATE: Jun, 2021
  • NO OF PAGES: 140